Clinical outcome of angiosome-oriented infrapopliteal percutaneous transluminal angioplasty for isolated @entity75 in XXXX with critical limb ischemia.

@entity75 @entity1 @entity6
PURPOSE: We aimed to evaluate the clinical usefulness and outcome of angiosome-oriented percutaneous transluminal angioplasty (IP-PTA) and its clinical outcome for isolated @entity75 in @entity6 . METHODS: We retrospectively reviewed 70 @entity1 (82 limbs) with @entity6 who had localized disease at the level of the infrapopliteal artery. @entity1 underwent IP-PTA between January 2011 and December 2013 and were followed up for a mean of 13 months. The primary target arterial lesions were chosen according to the angiosome concept. We evaluated clinical findings, technical success, and @entity1 ' clinical outcome. The angiographic outcome of IP-PTA was assessed using the angiosome score. We analyzed the relationship between the angiosome score and the amputation rate. RESULTS: There were 69 anterior tibial artery (ATA) lesions, 70 posterior tibial artery (PTA) lesions, and 58 peroneal artery (PA) lesions. The primary target arteries were the ATA (n=43), PTA (n=26), PA (n=2), and ATA + PTA (n=11). We divided the treated limbs into target (n=63) and nontarget (n=19) groups. The overall initial technical success rate was 91.4%. Successful wound healing rates were 87.3% (55/63) and 47.3% (9/19) in the target and nontarget groups, respectively (P < 0.05). CONCLUSION: Angiosome-oriented primary targeted IP-PTA shows a highly effective treatment outcome in @entity6 . In cases with inadequate angioplastic results of the target artery, IP-PTA of the nontarget artery should be recommended to improve the limb salvage rates.
